Literature DB >> 19945399

On mitochondria, mutations, and methodology.

Marc Vermulst, Jonathan Wanagat, Lawrence A Loeb.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19945399     DOI： 10.1016/j.cmet.2009.11.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


× No keyword cloud information.
  13 in total

Review 1.  Mitochondrial DNA replication and disease: insights from DNA polymerase γ mutations.

Authors:  Jeffrey D Stumpf; William C Copeland
Journal:  Cell Mol Life Sci       Date:  2010-10-08       Impact factor: 9.261

2.  Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.

Authors:  Laurie H Sanders; Jennifer McCoy; Xiaoping Hu; Pier G Mastroberardino; Bryan C Dickinson; Christopher J Chang; Charleen T Chu; Bennett Van Houten; J T Greenamyre
Journal:  Neurobiol Dis       Date:  2014-06-27       Impact factor: 5.996

Review 3.  Mitochondrial genome maintenance in health and disease.

Authors:  William C Copeland; Matthew J Longley
Journal:  DNA Repair (Amst)       Date:  2014-04-26

Review 4.  Clinical and molecular features of POLG-related mitochondrial disease.

Authors:  Jeffrey D Stumpf; Russell P Saneto; William C Copeland
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

5.  The mtDNA mutation spectrum of the progeroid Polg mutator mouse includes abundant control region multimers.

Authors:  Siôn L Williams; Jia Huang; Yvonne J K Edwards; Rick H Ulloa; Lloye M Dillon; Tomas A Prolla; Jeffery M Vance; Carlos T Moraes; Stephan Züchner
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

Review 6.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 7.  Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases.

Authors:  Karen L DeBalsi; Kirsten E Hoff; William C Copeland
Journal:  Ageing Res Rev       Date:  2016-04-30       Impact factor: 10.895

8.  LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.

Authors:  Evan H Howlett; Nicholas Jensen; Frances Belmonte; Faria Zafar; Xiaoping Hu; Jillian Kluss; Birgitt Schüle; Brett A Kaufman; J T Greenamyre; Laurie H Sanders
Journal:  Hum Mol Genet       Date:  2017-11-15       Impact factor: 6.150

9.  Linking the metabolic state and mitochondrial DNA in chronic disease, health, and aging.

Authors:  Martin Picard; Doug M Turnbull
Journal:  Diabetes       Date:  2013-03       Impact factor: 9.461

Review 10.  Nuclear and mitochondrial DNA repair in selected eukaryotic aging model systems.

Authors:  Ricardo Gredilla; Christian Garm; Tinna Stevnsner
Journal:  Oxid Med Cell Longev       Date:  2012-09-24       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.